anti-HIV1 antibody product blog
Tags: Antibody; Monoclonal Antibody; HIV1; anti-HIV1 antibody;
The HIV1 n/a (Catalog #MBS833233) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s HIV1 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).ELISA: 1:500-1:1000
WB: 1:500-1:1000
Binds to recombinant rev (HIV-1 HxB2, HxB3) in ELISA and Western Blot. Researchers should empirically determine the suitability of the HIV1 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal REV (HIV-1 HxB2, HxB3) antibody (FITC).
Biological Significance: Rev is a HIV gene. The name rev stands for "Regulator of Virion". The gene\'s protein product allows fragments of HIV mRNA that contain a Rev Response Element (RRE) to be exported from the nucleus to the cytoplasm. In the absence of the rev gene, the host RNA splicing machinery in the nucleus quickly splices the RNA so that only the smaller, regulatory proteins can be produced; in the presence of rev, RNA is exported from the nucleus before it can be spliced, so that the structural proteins and RNA genome can be produced. Biohazard Information: Not tested for sterility or endotoxin content.
Tag/Conjugate: FITC
Immunogen: HIV1, HxB2, HxB3 Rev antibody was raised in mouse using purified, full length rev (HIV-1 HxB2, HxB3) produced in E Coli Expression system as the immunogen.
Dry Ice Shipment: Extra charge fee may add to your shipping cost as dry ice is required to ship this product. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HIV1 are readily searchable from our website. Different antibodies against the same target such as HIV1 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.